Physician profile
Becky C Mann
NPI 1427071141
$3,956.06
in general payments reported to CMS, 2019-2025
12 companies · $2,165 in 2025
The $2,165 reported for 2025 was more than what 97% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $350 · 2021: $366 · 2022: $337 · 2023: $362 · 2024: $139 · 2025: $2,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,607 · Food and Beverage: $1,060.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,606.88 |
| Food and Beverage | $1,059.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,225.65 | 2020-2025 | Acuvue |
| Alcon Vision LLC | $849.01 | 2020-2025 | Total30, Precision 1, Dailies Total1 |
| Kala Pharmaceuticals, INC. | $135.20 | 2021-2022 | |
| Coopervision INC. | $119.85 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Carl Zeiss Meditec USA, INC. | $112.39 | 2023 | Clarus |
| Allergan, INC. | $108.70 | 2019 | |
| Maculogix, INC. | $97.57 | 2021 | |
| Bausch & Lomb Americas INC. | $97.10 | 2023 | Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $93.16 | 2019 | |
| Ocular Therapeutix, INC. | $88.46 | 2024 | |
| Carl Zeiss Meditec, INC. | $17.92 | 2019 | |
| Biotissue Holdings INC. | $11.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Becky Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.